Xencor to Host Third Quarter 2022 Financial Results Webcast and Conference Call on November 7, 2022

Author's Avatar
Oct 31, 2022

Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies and cytokines for the treatment of cancer and autoimmune diseases, today announced it will release third quarter 2022 financial results after the market closes on Monday, November 7, 2022.